Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
about
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effectsPharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.High-dose vitamin C therapy: renewed hope or false promise?Intravenously administered vitamin C as cancer therapy: three casesMegavitamin and megamineral therapy in childhood. Nutrition Committee, Canadian Paediatric SocietyUnconventional anticancer agents: a systematic review of clinical trialsPharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceLiving proof and the pseudoscience of alternative cancer treatmentsVitamin C: update on physiology and pharmacologyAntioxidants vitamin C and vitamin e for the prevention and treatment of cancerAscorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoDate (Phoenix dactylifera) Polyphenolics and Other Bioactive Compounds: A Traditional Islamic Remedy's Potential in Prevention of Cell Damage, Cancer Therapeutics and BeyondTreatment of Pancreatic Cancer with Pharmacological AscorbateAscorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progressionMitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Potential health risks of complementary alternative medicines in cancer patientsProof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapiesNew insights into the physiology and pharmacology of vitamin CCytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumoursAscorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cellsMechanisms of ascorbate-induced cytotoxicity in pancreatic cancerHigh doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy.The prospects of vitamin C in cancer therapySynergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapyUnconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.Unconventional therapies for cancer: a refuge from the rules of evidence?Hydrazine sulfate: a current perspective.Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.Nutritional aspects of ascorbic acid: uses and abusesPhase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress.Orthomolecular oncology review: ascorbic acid and cancer 25 years later.Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies.Reconvene and reconnect the antioxidant hypothesis in human health and disease.Review of high-dose intravenous vitamin C as an anticancer agent.Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer.Vitamin C deficiency in cancer patients.Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?Vitamin C and cancer revisited
P2860
Q21136326-88264249-F95C-4FAB-BCDB-68F5FEF549B4Q24531307-689B83D7-73F4-4134-A735-E25E44A4C8ACQ24540522-07A42964-2903-4CB9-BF89-D1761E6AE924Q24540524-F58FA421-F337-455D-B7D3-C99F033F8A19Q24545481-544EFA88-BF04-43D6-B543-E0B2D190F342Q24545903-962773B4-14C3-4E75-9316-B311CF110D31Q24644317-8872B706-6418-49EB-97A9-FF4E1E544864Q24646219-640BB166-148D-44F8-872C-C833BA10356AQ24654791-406494A3-50ED-42D6-A1A4-A61E7F58CAE0Q24670422-1A9262F9-01FC-4A1B-8E71-804303DC9931Q24678072-FB7862E9-F442-4DE9-BF9D-B5403D8FF86BQ26773409-CEEBA315-F35D-4FD7-96CD-866748276309Q26800853-53414A8A-1CCF-4AC2-87C8-7CF93B03FF3DQ26822640-97E5C6C7-4576-433C-ABCC-284B1A3E7F3EQ26852282-0F6B0153-6444-4FFA-9DE3-773D5EBF8136Q28166863-66C3845B-DB18-44B5-BC7F-9F87CC69C540Q28357644-75D63F45-7D84-47CF-B27E-F7CFD345E4FAQ28357822-C65DA99D-4C88-4564-B4D5-8919934DA917Q28366046-39FF6920-4E3C-4194-826F-9453BC582851Q28533798-3E1FB14A-EADF-4174-B604-CE0314DA4231Q30492805-F90486F9-5EC8-45BF-A5FF-FAA087FF2872Q33539100-31D0F04A-04E8-440E-AE24-5AAFCD40C088Q33631944-5F9C6A60-7D9A-49D5-A9F6-3135B30FEE0FQ33734981-FAB4675D-1CAD-41D8-95C8-2E36650037A1Q34028770-48BCED2D-2075-48C7-9E8E-A16E7F99D840Q34038676-D7F58C43-0542-4641-A89C-C2F390FB23BDQ34048977-D0FF6C2B-BA4B-4BD1-9E18-8192ADCD25D4Q34056834-F28622E9-A6E8-4F41-ADA0-F7C3E4B723B6Q34108998-4010F4DE-2B1C-4495-B8E5-6B2EA6578CFFQ34137350-2E35EBC0-3E4D-4D55-A631-700B92E15D23Q34253716-AF8C321D-70A1-49E1-9FC5-16AA1F7CD8C8Q34391627-40B857DE-2E28-4C95-BFEA-C83F3AAEEBB3Q34402953-33221D72-D93A-442A-AACA-6FF3315FFE05Q34405837-0F58ACA3-4E20-4708-B3E9-30DFF2A62DACQ34406887-590D16D9-5834-4F39-95D5-BE773F7CD83BQ34458788-9BF28094-E4AE-476D-8BF3-172D4954EC73Q34532488-4D88B98B-A9FA-4492-ABB1-D7EBD6AF4E19Q34554787-F0C7B5BC-54AB-4969-ABF4-AAC28D4FB59EQ34564943-1ABDDA54-58BB-4AD5-A4C6-BB0371278F03Q34595214-628E3550-267E-4DE2-A364-FD58A51BA1A5
P2860
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
description
1979 nî lūn-bûn
@nan
1979 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@ast
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@en
Failure of high-dose vitamin C
@nl
type
label
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@ast
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@en
Failure of high-dose vitamin C
@nl
prefLabel
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@ast
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@en
Failure of high-dose vitamin C
@nl
P2093
P1476
Failure of high-dose vitamin C ...... ed cancer. A controlled trial.
@en
P2093
Creagan ET
Moertel CG
O'Connell MJ
O'Fallon JR
P304
P356
10.1056/NEJM197909273011303
P407
P577
1979-09-01T00:00:00Z